Glucagonoma

Glucagonoma is an uncommon type of pancreatic neuroendocrine tumor arising from alpha cells that produce glucagon, a hormone responsible for regulating blood sugar levels. Excess secretion of glucagon disrupts normal metabolic balance, often resulting in diabetes mellitus, unintended weight loss, anemia, and a distinctive skin condition known as necrolytic migratory erythema. This rash typically appears as red, blistering patches that migrate across the body, serving as a hallmark sign of the disease.

Although glucagonoma progresses slowly compared to other malignancies, its symptoms can be debilitating and frequently overlooked due to their nonspecific nature. Patients may experience fatigue, diarrhea, depression, and nutritional deficiencies, which complicate diagnosis. Imaging techniques such as CT scans, MRI, and endoscopic ultrasound are essential for detecting the tumor, while blood tests measuring glucagon levels provide biochemical confirmation.

Treatment strategies depend on the stage of the disease. Surgical removal of the tumor offers the best chance for cure, while medications like somatostatin analogs help control hormone-related symptoms. In advanced cases, targeted therapies and chemotherapy may be considered. Early recognition and multidisciplinary management are crucial, as glucagonoma, though rare, can significantly impact quality of life if left untreated.